Daniel Kulp News Today

And what to do about it.

As the West Valley continues to grow and attract new residents, so does it appeal to entrepreneurs looking to expand their reach.

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight

Unlike many other retroviruses, HIV is an enveloped virus, enabling scientists to target the envelope for the induction of neutralizing antibodies in vaccine development efforts. Protein immunizations that induce autologous neutralizing antibodies (nAbs) against difficult to neutralize HIV strains (tier-2) require the stabilization of the HIV envelope into native-like trimer (NLT) conformations. A new study has encoded the HIV NLT into DNA and used this to successfully induce tier-2 nAbs in mice...

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. And many people are still not open in talking about it du

Get latest articles and stories on Health at LatestLY. Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. And many people are still not open in talking about it due to the stigma attached to it. However, a new study by researchers at The Wistar Institute has taken a promising step in the direction of developing an HIV vaccine. Health News | Scientists Develop Immunogen That Produces Tier-2 Antibodies Against HIV.

Nearly four decades after its discovery, HIV has killed 36.3 million people, with no vaccine in sight. However, a new study by researchers at The Wistar Institute, an international biomedical research leader in cancer, immunology, infectious disease, and vaccine development, takes a promising step in the direction of developing an HIV vaccine.

Scientists at The Wistar Institute have developed a more targeted COVID-19 vaccine that, in animal studies, shows stronger, broader, and more durable protection in a single, low dose.

The first generation of COVID-19 vaccines has been very effective; however, they do have certain limits. Their effectiveness can diminish without a booster shot, and they may be less effective against certain variants.

Scientists have developed new SARS-CoV-2 vaccines that provide stronger protection through a single dose and protect against emerging variants.